Partner in Transformation
A rare convergence of massive market opportunity, breakthrough technology moat, and measurable social impact.
Why Shiora, Why Now
The Structural Opportunity: Women's health has been systematically underserved for decades. Only 4% of healthcare R&D funding, 75% of clinical trials excluding women, and diagnostic delays averaging 4-7 years for common conditions.
The Market Inflection: We're at a unique moment where AI maturity, consumer demand, regulatory tailwinds, and capital interest are converging. The women's health market is projected to reach $50B+ by 2030, growing at 15%+ CAGR.
The Shiora Advantage: Our ABQS convergence architecture fusing AI, Blockchain, Quantum Computing, and Spatial Intelligence creates compound defensibility impossible to replicate with single-technology approaches.
Core Investment Merits
- Massive TAM with structural tailwinds
- Defensible technology moat (ABQS)
- Multiple revenue streams & exit paths
- Capital-efficient GTM strategy
- Measurable impact metrics (ESG/SDG aligned)
"Closing the women's health gap could boost global GDP by $1 trillion annually and add 7 healthy days per woman per year."
Global Institute, 2024
$50B+ Total Addressable Market
Women's health is one of the largest underserved markets in healthcare and one of the fastest growing.
Market Segments
Growth Drivers
- →Rising awareness and destigmatization
- →AI/ML enabling personalized care at scale
- →Regulatory push for sex-specific research
- →Corporate benefits expansion (fertility, menopause)
- →Government investment in maternal health
- →Venture capital flowing into FemTech
The ABQS Moat
Our convergence architecture creates compound defensibility that single-technology competitors cannot replicate.
Artificial Intelligence
SANA AI engine with 10M+ training data points. Predictive models for early detection, personalized care pathways.
Blockchain
Immutable health records. Patient-controlled data sovereignty. Transparent consent management.
Quantum Computing
QONTOS partnership for drug discovery, genomic analysis, and complex system modeling.
Spatial Intelligence
3D body mapping, AR-guided self-exams, geographic health pattern analysis.
Why ABQS Creates Unassailable Advantage
Data Network Effects
More users → richer data → better AI → improved outcomes → more users. Flywheel accelerates over time.
Integration Complexity
Competitors would need 4+ years to replicate our convergence stack. By then, our data advantage is insurmountable.
Zhyra Ecosystem
Access to sister companies (QONTOS, Zhilicon) provides technology at cost, accelerating our roadmap.
Multiple Revenue Streams
Diversified monetization across B2C, B2B, and B2B2C channels with strong unit economics.
Consumer Subscriptions
Premium memberships for personalized health insights, AI consultations, and care coordination.
Enterprise Solutions
White-label platform for employers, health plans, and healthcare systems. Per-member-per-month pricing.
Data & Research
Anonymized insights for pharma R&D, clinical trial recruitment, and academic research partnerships.
Government Contracts
Population health infrastructure for ministries of health. National deployment with data sovereignty compliance. Multi-year contracts with expansion options.
Marketplace & Partnerships
Curated marketplace for supplements, devices, and services. Affiliate revenue from telehealth, labs, and pharmacy partners. Transaction fees on care coordination.
Pre-Seed Funding Round
We are raising pre-seed capital to complete product development, achieve regulatory readiness, and execute our go-to-market strategy in the UAE and select international markets.
Use of Funds
Key Milestones (12-18 Months)
- MVP launch with 10,000+ beta users
- 2-3 enterprise pilot agreements
- HAAD/DOH regulatory approval (UAE)
- Seed round preparation ($3-5M target)
Pre-Seed Round
Target raise with SAFE notes
Strategic Capital Partners
We seek investors who bring more than capital: strategic value, domain expertise, and long-term alignment with our mission.
Sovereign Wealth Funds
Long-term patient capital aligned with national health and economic diversification priorities. Ideal for government partnerships.
Institutional Investors
Healthcare-focused VCs and growth equity funds seeking exposure to the convergence of AI, digital health, and women's health markets.
UHNW Individuals
Strategic angels with healthcare, technology, or regional expertise. Family offices with multi-generational investment horizons and impact focus.
Impact Investors
ESG-focused funds and foundations seeking measurable outcomes. SDG 3 (Health) and SDG 5 (Gender Equality) alignment with financial returns.
Growth Projections
Conservative base case with significant upside potential as we capture market share in a rapidly expanding sector.
Investment Inquiries
Ready to learn more? Contact our investor relations team to receive our detailed pitch deck, financial model, and schedule a conversation with leadership.
Headquarters
Abu Dhabi, UAE
Disclaimer
This page is for informational purposes only and does not constitute an offer to sell or solicitation of an offer to buy securities. Investment opportunities are available only to accredited investors. Past performance is not indicative of future results. Prospective investors should conduct their own due diligence and consult with financial, legal, and tax advisors before making investment decisions.